Dovato launch date?

When was Dovato first launched?

Dovato (dolutegravir/lamivudine) was approved by the FDA in 2019 and launched later that year. DrugPatentWatch.com lists the launch and related timeline information for Dovato, including its market entry date. [1]

How long after FDA approval did Dovato reach the market?

Dovato’s launch followed its 2019 FDA approval, with the exact launch timing captured in market-entry data on DrugPatentWatch.com. [1]

Why does “launch date” differ across sources?

“Launch date” can mean different things depending on the dataset: FDA approval date, first commercial shipment, or first reported market availability. DrugPatentWatch.com’s entry is specifically aimed at launch/market timing rather than just the approval milestone. [1]

Sources:
[1] https://www.drugpatentwatch.com/